Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy

With more than 25 million people affected, heart failure (HF) is a global threat. As energy production pathways are known to play a pivotal role in HF, we sought here to identify key metabolic changes in ischemic- and non-ischemic HF by using a multi-OMICS approach. Serum metabolites and mRNAseq and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Haas, Jan, Frese, Karen S., Sedaghat-Hamedani, Farbod, Kayvanpour, Elham, Tappu, Rewati, Nietsch, Rouven, Tugrul, Oguz Firat, Wisdom, Michael, Dietrich, Carsten, Amr, Ali, Weis, Tanja, Niederdränk, Torsten, Murphy, Michael P., Krieg, Thomas, Dörr, Marcus, Völker, Uwe, Fielitz, Jens, Frey, Norbert, Felix, Stephan B., Keller, Andreas, Katus, Hugo A., Meder, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923201/
https://ncbi.nlm.nih.gov/pubmed/33670449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041999
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares